Skip to main content
Volume 11, No 3 - Summer 2010

Volume 11, No 3 - Summer 2010

Table of Contents

The Impact of Public Smoking Ban on the Incidence of Myocardial Infarction Hospitalizations Disease State Review
Smoking is a well-established risk factor for cardiovascular disease (CVD) and acute myocardial infarction (AMI). Exposure to tobacco smoke is associated with an estimated 35,000 cardiovascular deaths per year in nonsmokers. In addition, the risk of CVD decreases with the cessation of exposure to smoking. Association of smoking with CVD has been well known for years; however, association of secondhand smoke with CVD has been a topic of great interest, especially for the past 2 decades. Multiple studies and articles have evaluated the impact of smoking ban on the incidence of AMI-related hospitalizations.|In this article, we discuss the effect of smoking ban on the economy and on human health in general, as well as its potential effects on the prevalence of smoking. [Rev Cardiovasc Med. 2010;11(3):e121-e129 doi: 10.3909/ricm0540]
Update on Cardiac Risk Stratification of Renal Transplant Candidates Management Update
Numerous modifiable and unmodifiable risk factors have been identified that contribute to increased cardiovascular risk in renal transplant recipients. We reviewed several clinical studies and journal articles to identify these risk factors in an attempt to risk stratify chronic kidney disease patients who are candidates for renal transplantation. Cardiovascular disease has been identified as the leading cause of death with graft function among renal transplant recipients. No single test or diagnostic modality has been found to provide complete diagnostic and prognostic information. Hence, a combination of clinical, biochemical, and radiographic data is essential to risk stratify renal transplantation candidates.[Rev Cardiovasc Med. 2010;11(3):e130-e140 doi: 10.3909/ricm0547]
Progesterone, Progestins, and the Heart Treatment Update
All combination hormone replacement regimens contain estrogen and a progestational agent. The Women’s Health Initiative trial demonstrated that taking the combination of conjugated estrogen and medroxyprogesterone resulted in a higher risk of myocardial infarction and stroke in the study population. However, not all progestational agents are alike in their cardiovascular properties. This article reviews what is known about the most commonly prescribed agents: progesterone, medroxyprogesterone, norethindrone, and norethindrone acetate. We compare data on markers of lipid metabolism, inflammation, and clotting function, and review studies that measure their direct effects on cardiac vessels.[Rev Cardiovasc Med. 2010;11(3):e141-e149 doi: 10.3909/ricm0557]
Best of the ACC 2010 Scientific Session Meeting Review
Highlights From the 59th Annual American College of Cardiology Scientific Session, March 14-16, 2010, Atlanta, GA[Rev Cardiovasc Med. 2010;11(3):e153-e163 doi: 10.3909/ricm0554]
Society for Cardiovascular Magnetic Resonance: Advances in Research and Clinical Applications Meeting Review
Highlights From the 13th Annual SCMR Scientific Sessions, January 21-24, 2010, Phoenix, AZ [Rev Cardiovasc Med. 2010;11(3):e164-e169 doi: 10.3909/ricm0559]
Giant Saphenous Vein Graft Aneurysm Causing Left Atrial Compression and Cardiogenic Shock Case Review
Saphenous vein graft aneurysm is a rare complication of coronary artery bypass graft (CABG) surgery that is challenging to manage and is associated with catastrophic consequences. We present the case of a 72-year-old woman with prior CABG surgery who presented with chest pain and was found to have a giant saphenous vein graft pseudoaneurysm. Further evaluation revealed that a vein graft pseudoaneurysm was causing significant compression of the left atrium. The pseudoaneurysm was successfully excluded from the blood flow with a covered stent; however, despite intra-aortic balloon pump and supportive therapy, the patient succumbed to cardiogenic shock and sepsis.|[Rev Cardiovasc Med. 2010;11(3):e170-e175 doi: 10.3909/ricm0541]
Recurrent Asymptomatic Right Atrial Myxoma Case Review
Cardiac myxoma is the most common primary tumor of the heart. The clinical presentation ranges from asymptomatic to symptomatic with constitutional symptoms, obstructive symptoms, or evidence of embolism. Most cases are sporadic; recurrence rates are low after surgical excision for these cases. We present a case of an asymptomatic right atrial myxoma which recurred 1 year after its resection.|[Rev Cardiovasc Med. 2010;11(3):e176-e180 doi: 10.3909/ricm0542]